AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
GENTAMYCIN SULFATE
5 registrations across 3 African markets— 4 active
Markets with GENTAMYCIN SULFATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Oncenix Injection | 🇰🇪Kenya | Lofral-5 mg Tablets | active | Jul 2026 |
| GENTAMYCIN 0.3% EYE/EAR DROPS EYE/EAR DROPS | 🇲🇼Malawi | — | expired | Jun 2012 |
| GENTAMEDINE Solution for injection | 🇹🇿Tanzania | Beijing Holley Cotec Pharmaceuticals Co., Ltd | active | — |
| Gentamicin Injection 80mg/2ml Solution for injection | 🇹🇿Tanzania | MORAF PHARMACEUTICALS LTD | active | — |
| GENTALPHA liquid injection | 🇹🇿Tanzania | SALAMA PHARMACEUTICALS LIMITED | active | — |
GENTAMYCIN SULFATE in Africa — Regulatory Overview
GENTAMYCIN SULFATE is registered across 3 African markets with 5 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, Kenya, Malawi. AfricaRegulatory refreshes this data daily from official government sources.
Of the 5 registrations, 4 (80%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.